MedPath

Evaluation of the efficacy of sofosbuvir and ledipasvir for Japanese hepatitis C patients: a prospective study in real-life settings.

Not Applicable
Recruiting
Conditions
chronic hepatitis C
Registration Number
JPRN-UMIN000019468
Lead Sponsor
Toranomon Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

decompensated cirrhosis coexisting heart disease renal impairment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sustained virological response (SVR) at 12 week and 24 week after the end of treatment
Secondary Outcome Measures
NameTimeMethod
incidence rate of adverse events
© Copyright 2025. All Rights Reserved by MedPath